[Chronic cerebrovascular diseases and neuroprotection: the clinical efficacy of meldonium (Mildronat)].

M M Tanashyan M Yu Maksimova P A Fedin R B Medvedev T A Bolotova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)

Nootropic, anxiolytic and antitrombogenic effects of meldonium (mildronat) in patients with chronic CVD are demonstrated that makes it possible to recommend this drug for widespread use by specialists in clinical practice.

Keyphrases

clinical practice
brain injury
drug induced
cerebral ischemia
adverse drug
emergency department
subarachnoid hemorrhage
blood brain barrier